135 related articles for article (PubMed ID: 30948314)
1. Long-term glioblastoma survival following recovery from cytomegalovirus colitis: A case report.
Lamano JB; Quaggin-Smith JA; Horbinski CM; Tate MC; Grimm SA; Kumthekar PU; Bloch O
J Clin Neurosci; 2019 Jun; 64():18-21. PubMed ID: 30948314
[TBL] [Abstract][Full Text] [Related]
2. The detection of CMV pp65 and IE1 in glioblastoma multiforme.
Lucas KG; Bao L; Bruggeman R; Dunham K; Specht C
J Neurooncol; 2011 Jun; 103(2):231-8. PubMed ID: 20820869
[TBL] [Abstract][Full Text] [Related]
3. Is CMV a target in pediatric glioblastoma? Expression of CMV proteins, pp65 and IE1-72 and CMV nucleic acids in a cohort of pediatric glioblastoma patients.
Wakefield A; Pignata A; Ghazi A; Ashoori A; Hegde M; Landi D; Gray T; Scheurer ME; Chintagumpala M; Adesina A; Gottschalk S; Hicks J; Powell SZ; Ahmed N
J Neurooncol; 2015 Nov; 125(2):307-15. PubMed ID: 26341370
[TBL] [Abstract][Full Text] [Related]
4. Recognition and killing of autologous, primary glioblastoma tumor cells by human cytomegalovirus pp65-specific cytotoxic T cells.
Nair SK; De Leon G; Boczkowski D; Schmittling R; Xie W; Staats J; Liu R; Johnson LA; Weinhold K; Archer GE; Sampson JH; Mitchell DA
Clin Cancer Res; 2014 May; 20(10):2684-94. PubMed ID: 24658154
[TBL] [Abstract][Full Text] [Related]
5. Generation of polyclonal CMV-specific T cells for the adoptive immunotherapy of glioblastoma.
Ghazi A; Ashoori A; Hanley PJ; Brawley VS; Shaffer DR; Kew Y; Powell SZ; Grossman R; Grada Z; Scheurer ME; Hegde M; Leen AM; Bollard CM; Rooney CM; Heslop HE; Gottschalk S; Ahmed N
J Immunother; 2012; 35(2):159-68. PubMed ID: 22306904
[TBL] [Abstract][Full Text] [Related]
6. Co-ordinated isolation of CD8(+) and CD4(+) T cells recognizing a broad repertoire of cytomegalovirus pp65 and IE1 epitopes for highly specific adoptive immunotherapy.
Zandvliet ML; van Liempt E; Jedema I; Veltrop-Duits LA; Willemze R; Guchelaar HJ; Falkenburg JH; Meij P
Cytotherapy; 2010 Nov; 12(7):933-44. PubMed ID: 20078388
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.
Vaz-Santiago J; Lulé J; Rohrlich P; Jacquier C; Gibert N; Le Roy E; Betbeder D; Davignon JL; Davrinche C
J Virol; 2001 Sep; 75(17):7840-7. PubMed ID: 11483727
[TBL] [Abstract][Full Text] [Related]
8. Influence of HIV infection on cytomegalovirus-specific immunity: T-cell responses to pp65 and IE1 before and after HAART may reflect altered cytomegalovirus biology.
Scherrenburg J; Schellens IM; van Baarle D
Antivir Ther; 2011; 16(4):565-75. PubMed ID: 21685544
[TBL] [Abstract][Full Text] [Related]
9. Monitoring cytomegalovirus IE-1 and pp65-specific CD4+ and CD8+ T-cell responses after allogeneic stem cell transplantation may identify patients at risk for recurrent CMV reactivations.
Gratama JW; Brooimans RA; van der Holt B; Sintnicolaas K; van Doornum G; Niesters HG; Löwenberg B; Cornelissen JJ
Cytometry B Clin Cytom; 2008 Jul; 74(4):211-20. PubMed ID: 18454493
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Specific CD4+ and CD8+ T Cells Stimulated by CMV pp65 and IE1 Antigens.
Albiero E; Amati E; Baumeister E; Einsele H; Grigoleit GU; Rodeghiero F
J Immunother; 2016; 39(9):329-342. PubMed ID: 27631893
[TBL] [Abstract][Full Text] [Related]
11. Glioblastoma-mediated Immune Dysfunction Limits CMV-specific T Cells and Therapeutic Responses: Results from a Phase I/II Trial.
Weathers SP; Penas-Prado M; Pei BL; Ling X; Kassab C; Banerjee P; Bdiwi M; Shaim H; Alsuliman A; Shanley M; de Groot JF; O'Brien BJ; Harrison R; Majd N; Kamiya-Matsuoka C; Fuller GN; Huse JT; Chi L; Rao G; Weinberg JS; Lang FF; Sawaya R; Shpall EJ; Rezvani K; Heimberger AB
Clin Cancer Res; 2020 Jul; 26(14):3565-3577. PubMed ID: 32299815
[TBL] [Abstract][Full Text] [Related]
12. Human cytomegalovirus-mediated immunomodulation: Effects on glioblastoma progression.
Foster H; Ulasov IV; Cobbs CS
Biochim Biophys Acta Rev Cancer; 2017 Aug; 1868(1):273-276. PubMed ID: 28554666
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus (CMV) IE1- and pp65-specific CD8+ T cell responses broaden over time after primary CMV infection in infants.
Gibson L; Dooley S; Trzmielina S; Somasundaran M; Fisher D; Revello MG; Luzuriaga K
J Infect Dis; 2007 Jun; 195(12):1789-98. PubMed ID: 17492595
[TBL] [Abstract][Full Text] [Related]
14. Glioma-associated cytomegalovirus mediates subversion of the monocyte lineage to a tumor propagating phenotype.
Dziurzynski K; Wei J; Qiao W; Hatiboglu MA; Kong LY; Wu A; Wang Y; Cahill D; Levine N; Prabhu S; Rao G; Sawaya R; Heimberger AB
Clin Cancer Res; 2011 Jul; 17(14):4642-9. PubMed ID: 21490182
[TBL] [Abstract][Full Text] [Related]
15. Cellular and humoral immune responses to alphavirus replicon vaccines expressing cytomegalovirus pp65, IE1, and gB proteins.
Reap EA; Dryga SA; Morris J; Rivers B; Norberg PK; Olmsted RA; Chulay JD
Clin Vaccine Immunol; 2007 Jun; 14(6):748-55. PubMed ID: 17442845
[TBL] [Abstract][Full Text] [Related]
16. Cytomegalovirus-targeted immunotherapy and glioblastoma: hype or hope?
Ferguson SD; Srinivasan VM; Ghali MG; Heimberger AB
Immunotherapy; 2016; 8(4):413-23. PubMed ID: 26973123
[TBL] [Abstract][Full Text] [Related]
17. Human cytomegalovirus proteins pp65 and immediate early protein 1 are common targets for CD8+ T cell responses in children with congenital or postnatal human cytomegalovirus infection.
Gibson L; Piccinini G; Lilleri D; Revello MG; Wang Z; Markel S; Diamond DJ; Luzuriaga K
J Immunol; 2004 Feb; 172(4):2256-64. PubMed ID: 14764694
[TBL] [Abstract][Full Text] [Related]
18. Dendritic Cells Enhance Polyfunctionality of Adoptively Transferred T Cells That Target Cytomegalovirus in Glioblastoma.
Reap EA; Suryadevara CM; Batich KA; Sanchez-Perez L; Archer GE; Schmittling RJ; Norberg PK; Herndon JE; Healy P; Congdon KL; Gedeon PC; Campbell OC; Swartz AM; Riccione KA; Yi JS; Hossain-Ibrahim MK; Saraswathula A; Nair SK; Dunn-Pirio AM; Broome TM; Weinhold KJ; Desjardins A; Vlahovic G; McLendon RE; Friedman AH; Friedman HS; Bigner DD; Fecci PE; Mitchell DA; Sampson JH
Cancer Res; 2018 Jan; 78(1):256-264. PubMed ID: 29093005
[TBL] [Abstract][Full Text] [Related]
19. Validation of T-Track® CMV to assess the functionality of cytomegalovirus-reactive cell-mediated immunity in hemodialysis patients.
Banas B; Böger CA; Lückhoff G; Krüger B; Barabas S; Batzilla J; Schemmerer M; Köstler J; Bendfeldt H; Rascle A; Wagner R; Deml L; Leicht J; Krämer BK
BMC Immunol; 2017 Mar; 18(1):15. PubMed ID: 28270092
[TBL] [Abstract][Full Text] [Related]
20. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells.
Bunde T; Kirchner A; Hoffmeister B; Habedank D; Hetzer R; Cherepnev G; Proesch S; Reinke P; Volk HD; Lehmkuhl H; Kern F
J Exp Med; 2005 Apr; 201(7):1031-6. PubMed ID: 15795239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
